BackNorth China Pharmaceutical Company Overview
North China Pharmaceutical Company Ltd.

North China Pharmaceutical Company PEG Ratio

Latest PEG ratio for North China Pharmaceutical Company: -147.1 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-147.10

PEG Ratio

-147.10

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

North China Pharmaceutical Company (600812.SS) FAQ

North China Pharmaceutical Company posts a PEG ratio of -147.1. That is below the sector sector average of 10.05. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a PEG ratio near 10.05 is typical. North China Pharmaceutical Company's -147.1 is lower that level. That is roughly 1562.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

North China Pharmaceutical Company's PEG ratio of -147.1 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for 600812.SS's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.05), and (3) consistency with growth and profitability. This page covers the first two; North China Pharmaceutical Company's other metric pages and overview cover the third.